AU market earnings: Ingham's profit soars 68% as Telix Pharmaceuticals reverses loss
Ingham's profit rises 68% to $101.5 million, Telix Pharmaceuticals reports $29.7 million profit, reversing a loss, while Accent Group's profit falls 33%, plans asset sales and store expansions.
[AI generated]
This video was created on 23 August for IG audiences by ausbiz.
Ingham's profit soars, Telix reverses loss, and Accent faces decline
Ingham's profit rises 68% to $101.5 million, supported by revenue growth, but the company anticipates challenges in FY25 due to cost pressures. Telix Pharmaceuticals achieved a $29.7 million profit, reversing last year's loss, while Accent Group faced a 33% profit decline, planning to sell non-productive assets and expand store locations.
Centuria Capital reported a slight profit dip, focusing on capital management amid stable assets under management. Broker moves include Citi's raised target for Northern Star Resources and Morgans' upgrade of Megaport, despite lowering earnings forecasts.
IGA, may distribute information/research produced by its respective foreign affiliates within the IG Group of companies pursuant to an arrangement under Regulation 32C of the Financial Advisers Regulations. Where the research is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, IGA accepts legal responsibility for the contents of the report to such persons only to the extent required by law. Singapore recipients should contact IGA at 6390 5118 for matters arising from, or in connection with the information distributed.
The information/research herein is prepared by IG Asia Pte Ltd (IGA) and its foreign affiliated companies (collectively known as the IG Group) and is intended for general circulation only. It does not take into account the specific investment objectives, financial situation, or particular needs of any particular person. You should take into account your specific investment objectives, financial situation, and particular needs before making a commitment to trade, including seeking advice from an independent financial adviser regarding the suitability of the investment, under a separate engagement, as you deem fit.
No representation or warranty is given as to the accuracy or completeness of this information. Consequently, any person acting on it does so entirely at their own risk. Please see important Research Disclaimer.
Please also note that the information does not contain a record of our trading prices, or an offer of, or solicitation for, a transaction in any financial instrument. Any views and opinions expressed may be changed without an update.
Explore the markets with our free course
Discover and learn how the range of markets you can trade on with IG Academy's online course – ‘Introducing the financial markets’.
Put learning into action
Try out what you’ve learned in this shares strategy article risk-free in your demo account.
Ready to trade shares?
Put the lessons in this article to use in a live account – upgrading is quick and easy.
- Trade on over 10,000 popular global stocks
- Protect your capital with risk management tools
- React to breaking news with out-of-hours trading on 70 key US stocks
Inspired to trade?
Put your new knowledge into practice. Log in to your account now.
Live prices on most popular markets
- Forex
- Shares
- Indices
See more forex live prices
See more shares live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 15 mins.
See more indices live prices
Prices above are subject to our website terms and agreements. Prices are indicative only. All shares prices are delayed by at least 20 mins.
